Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VET EPISTAT AS
AS
Active
Org 930760773
Morbergrønningen 52, 3470 Slemmestad
Business and other management consultancy activities · NACE 7020
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 179K
+14% vs 2023
EBITDA margin
82.2%
+6% vs 2023
Equity ratio
81.2%
Financial strength
Net profit 2024
NOK 115K
+6% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 179K
+14%
EBITDA
NOK 147K
+6%
Net profit
NOK 115K
+6%
Total assets
NOK 180K
+7%
Equity
NOK 146K
+371%
Employees
0
—
Company information
Legal name
VET EPISTAT AS
Org number
930760773
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
2. februar 2023
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Statistiske og epidemiologiske analyser og faglige vurderinger innen veterinærfaget.
Contact
Address
Morbergrønningen 52, 3470 Slemmestad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Asker
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
157
179
Staff expenses
−0
−0
−0
EBITDA
0
138
147
Depreciation & amort.
−0
−0
−0
EBIT
0
138
147
Net financials
0
0
0
Profit before tax
0
138
147
Tax
−0
30
32
Net profit
0
108
115
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
30
169
180
Equity
30
31
146
Long-term debt
0
0
0
Short-term debt
0
138
34
Total debt
0
138
34
Financial ratios
5-year trend
EBITDA margin
82.2%
This company
15.8%
Market median
+420% vs market
2022
2024
Equity ratio
81.2%
This company
38.2%
Market median
+113% vs market
2022
2024
Return on equity
78.8%
This company
18.4%
Market median
+328% vs market
2022
2024
Net profit margin
64.2%
This company
8.1%
Market median
+693% vs market
2022
2024
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
2022
2024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
ES
Eystein Skjerve
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of VET EPISTAT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Eystein Skjerve
Chairman
0 companies